Clinical Trials Directory

Trials / Completed

CompletedNCT00213915

L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function

Effects of Oral Chronic L-arginine Supplementation on Exercise and Renal Function of Heart Transplant Recipients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (planned)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

* exercise capacities are still altered after heart transplantation partly due to peripheral endothelial dysfunction * cyclosporin-induced renal dysfunction may be due to renal endothelial dysfunction and can be reversed in an animal model by L-arginine supplementation * to determine the potential beneficial effect of L-arginine supplementation on exercise capacity and renal function of heart transplant recipients

Conditions

Interventions

TypeNameDescription
DRUG12 g of L-arginine glutamate during 6 weeks twice a day

Timeline

Start date
2004-02-01
Completion
2004-12-01
First posted
2005-09-21
Last updated
2025-12-22

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00213915. Inclusion in this directory is not an endorsement.